The association between cardiovascular risk and cardiovascular magnetic resonance measures of fibrosis: The Multi-Ethnic Study of Atherosclerosis (MESA)

Journal of Cardiovascular Magnetic Resonance

Volumn 17, Issue 1, 2015, Pages

  Yi, Colin J ^a   Wu, Colin O ^h   Tee, Michael ^a   Liu, Chia Ying ^a   Volpe, Gustavo J ^b   Prince, Martin R ^c   Hundley, Gregory W ^d   Gomes, Antoinette S ^e   Van Der Geest, Rob J ^f   Heckbert, Susan ^g   Lima, João A ^b   Bluemke, David A ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Cardiovascular magnetic resonance; Myocardium; Risk factors

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN AMERICAN; BOOTSTRAPPING; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CAUCASIAN; CORRELATION ANALYSIS; EXTRACELLULAR SPACE; FEMALE; HEART MUSCLE FIBROSIS; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARTITION COEFFICIENT; PRIORITY JOURNAL; REYNOLDS RISK SCORE; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; AGE; ANALYSIS OF VARIANCE; CARDIAC MUSCLE; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; FIBROSIS; HEART DISEASES; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; UNITED STATES; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COMORBIDITY; CONTRAST MEDIA; FEMALE; FIBROSIS; GADOLINIUM; HEART DISEASES; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; UNITED STATES;

EID: 84924071420     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/s12968-015-0121-5     Document Type: Article

References (33)

1. Kannel WB, Kagan A, Stokes J, Dawber TR, Revotskie N. Factors of Risk in Development of Coronary Heart Disease - 6-Year Follow-up Experience. Ann Intern Med. 1961;55:33-50.
2. Bitton A, Gaziano T. The Framingham Heart Study's Impact on Global Risk Assessment. Prog Cardiovasc Dis. 2010;53:68-78.
3. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol. 1976;38:46-51.
4. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83:356-62.
5. Goff Jr DC, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino Sr RB, Gibbons R, et al. ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;63:3026.
6. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, et al. Coronary Artery Calcium Score and Risk Classification for Coronary Heart Disease Prediction. J Am Med Assoc. 2010;303:1610-6.
7. Pitt B, Zannad F. The detection of myocardial fibrosis: an opportunity to reduce cardiovascular risk in patients with diabetes mellitus? Circ Cardiovasc Imaging. 2012;5:9-11.
8. Donekal S, Lima JAC. Diffuse Interstitial Myocardial Fibrosis by T1 Myocardial Mapping: Review. Transl Med. 2013;3:111.
9. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR, et al. Gender Differences and Aging - Effects on the Human Heart. J Am Coll Cardiol. 1995;26:1068-79.
10. Kania G, Blyszczuk P, Eriksson U. Mechanisms of Cardiac Fibrosis in Inflammatory Heart Disease. Trends Cardiovas Med. 2009;19:247-52.
11. Goette A, Lendeckel U, Kuchenbecker A, Bukowska A, Peters B, Klein HU, et al. Cigarette smoking induces atrial fibrosis in humans via nicotine. Heart. 2007;93:1056-63.
12. Zulli A, Hare DL, Buxton BF, Black MJ. The combination of high dietary methionine plus cholesterol induces myocardial fibrosis in rabbits. Atherosclerosis. 2006;185:278-81.
13. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52:1574-80.
14. Flett AS, Sado DM, Quarta G, Mirabel M, Pellerin D, Herrey AS, et al. Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging. 2012;13:819-26.
15. White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS, et al. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging. 2013;6:955-62.
16. Fontana M, White SK, Banypersad SM, Sado DM, Maestrini V, Flett AS, et al. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson. 2012;14:88.
17. Sibley CT, Noureldin RA, Gai N, Nacif MS, Liu ST, Turkbey EB, et al. T1 Mapping in Cardiomyopathy at Cardiac MR: Comparison with Endomyocardial Biopsy. Radiology. 2012;265:724-32.
18. Bild DE, Bluemke DA, Burke GL, Detrano R, Roux AVD, Folsom AR, et al. Multi-ethnic study of atherosclerosis: Objectives and design. Am J Epidemiol. 2002;156:871-81.
19. Friedewa WT, Fredrick DS, Levy RI. Estimation of Concentration of Low- Density Lipoprotein Cholesterol in Plasma, without Use of Preparative Ultracentrifuge. Clin Chem. 1972;18:499-502.
20. Choi EY, Bahrami H, Wu CO, Greenland P, Cushman M, Daniels LB, et al. N-terminal Pro-B-Type Natriuretic Peptide, Left Ventricular Mass, and Incident Heart Failure Multi-Ethnic Study of Atherosclerosis. Circ Heart Fail. 2012;5:727-34.
21. Liu CY, Liu YC, Wu C, Armstrong A, Volpe GJ, Van der Geest RJ, et al. Evaluation of Age-Related Interstitial Myocardial Fibrosis With Cardiac Magnetic Resonance Contrast-Enhanced T-1 Mapping MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013;62:1280-7.
22. Allan GM, Nouri F, Korownyk C, Kolber MR, Vandermeer B, McCormack J. Agreement Among Cardiovascular Disease Risk Calculators. Circulation. 2013;127:1948-56.
23. Edinburgh: Framingham CVD, ASSIGN, BNF, and Framingham CHD. Payne R. Cardiovascular Risk Calculators [Internet]. Edinburgh, UK: University of Edinburgh; 2005.
24. Ahmed HM, Blaha MJ, Nasir K, Jones SR, Rivera JJ, Agatston A, et al. Low-Risk Lifestyle, Coronary Calcium, Cardiovascular Events, and Mortality: Results From MESA. Am J Epidemiol. 2013;178:12-21.
25. Sullivan LM, Dukes KA, Losina E. Tutorial in biostatistics An introduction to hierarchical linear modelling. Stat Med. 1999;18:855-88.
26. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations - A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 1999;34:1348-59.
27. Kent JT, Davison AC, Silverman BW, Young GA, Daniels HE, Tong H, et al. Bootstrap Methods - a Review of Bootstrap Confidence-Intervals - Discussion. J R Stat Soc B Methodol. 1988;50:355-70.
28. Flacke SJ, Fischer SE, Lorenz CH. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology. 2001;218:703-10.
29. Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, et al. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging. 2013;6:392-8.
30. Thompson RB, Chow K, Khan A, Chan A, Shanks M, Paterson I, et al. T(1) mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex. Circ Cardiovasc Imaging. 2013;6:637-45.
31. Pitt B, Zannad F. The Detection of Myocardial Fibrosis An Opportunity to Reduce Cardiovascular Risk in Patients With Diabetes Mellitus? Circ Cardiovasc Imag. 2012;5:9-11.
32. Potluri R, Miller CA, Schmitt M. Interrelationship of LV mass, focal fibrosis by LGE, and diffuse fibrosis by T1-changes in patients with hypertrophic cardiomyopathy. J Cardiovasc Magn R. 2012;14:P166.
33. Zhang R, Zhang YY, Huang XR, Wu Y, Chung AC, Wu EX, et al. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease. Hypertension. 2010;55:953-60.